A CWG Working Paper · September 2026. How Municipal Opt-Out Sets the Terms on Both Sides of the Market — in the Words of Twenty-Four Operators. By Max Jackson. Twenty-four interviews with New Jersey cannabis license holders and applicants, first half of 2026. 120 pages.

Executive summary

New Jersey signed medical cannabis into law on Governor Corzine’s last day in office, January 18, 2010; by the time voters legalized adult use a decade later, nine Alternative Treatment Centers were the entire program. The legislature followed four months after the referendum with CREAMMA, creating the Cannabis Regulatory Commission and handing each of the state’s 564 municipalities the power to opt out of hosting any licensed cannabis business. Most of them used it. When adult-use sales opened on April 21, 2022, the market was seven ATC parent companies at thirteen dispensary locations, and no independent cultivator reached a shelf for approximately seventeen months after that — a time in which the incumbents set every consumer habit in the state before a competitor could put a jar beside theirs. Four years in: a $1.16 billion market¹, 322 dispensaries, 71 operating cultivators out of 384 to 439 licensed, and 386 of the state’s 564 municipalities still closed to cultivation.

Over the first half of 2026 I sat down with twenty-four New Jersey cannabis license holders and applicants — twenty-one holding cultivation licenses at every stage from profitable to still building to gave-up-before-a-plant-went-in-the-ground, two who abandoned the application process outright, and one retailer building cultivation alongside a store — and asked each of them, in plain terms, how they got in, what it cost, and what was keeping them up at night. They are not a focus group. They are the market — every scale the state licenses except the publicly traded multistate operators. None of them runs in more than one state today; this is the independent side of the market talking, and the one operator among them who ever held a license in a second state sold that business before we spoke. They share no common story but the New Jersey market. Ten of them named the same wall before the interview ever reached it — and nearly all the rest confirmed it the moment it came up.

Not the regulator. The town.

That convergence is the finding. A single grower blaming the system is a grievance. Ten operators who came in through different doors and share little else, naming the same barrier in answer to an open question about what had been hardest — before the word “municipal” had been said in the interview — are evidence. And when the question did come up, operator after operator confirmed it: one answered “100%” without hesitation; another laid out the town’s delays in granular detail. Only two operators in the entire cohort said municipalities were never a barrier at all. And the most disarming part is who is saying it. The operators with the least to say against the Cannabis Regulatory Commission are the ones who still could not get into the market. One operator who left a previous career for a cultivation license volunteered that the Commission’s operator-training program “knocked it out of the park,” then described the separate state agency that tied his site up for months and the processing delay that handed his competitors the market before he could open. The witnesses who clear the regulator point, together, at local control.

The thesis follows from the convergence: municipal opt-out is the structural failure, and it radiates into both sides of the market at once. New Jersey handed each of its 564 towns the power to ban licensed cannabis at the local line, and most of them used it. As of mid-2026, 386 of the 564 — more than two-thirds — do not permit licensed cultivation at all; a grower looking for a home has 178 towns to choose from, not 564.² On the supply side, that map collapses a grower’s search to a fraction of the state, then turns even that fraction into a multi-year gauntlet of towns, buildings, and land regimes that screens out the farmers and the under-capitalized the law was written to include. On the demand side, the same map leaves most of the state — 62% of the population — without adequate access to a legal store, and the seller who served them before legalization never left.³

Both ends run downhill to a single number: the wholesale price of a pound of flower. Wholesale prices fall in every maturing cannabis market — that is gravity, not New Jersey’s invention. New Jersey’s fell 30.8% across eight quarters, from $2,964 to $2,051, on its way toward the $1,200 floor operators in this cohort keep arriving at.⁴ Opt-out did not create the decline. It accelerated and deepened it — forcing supply through a fraction of the state’s doors and manufacturing a price war on top of a slide that was coming anyway. The grower who survives the town, the building, the land, and the capital gauntlet does not arrive at an open market. She arrives at one that price war has already hollowed, sells into stores that write a 90-day term and stretch it past 120, and gets consolidated by whoever had the capital to wait her out. The grower who won his license through a competitive round and turns a profit today does not believe the door stays open behind him: “No new brands going to be able to enter it.”

The scale of the gap has its own number, and getting it right required looking past the published total. The Cannabis Regulatory Commission’s quarterly report shows a Grand Total of 548 cultivation licenses — a figure we used ourselves until we realized it counts board actions, not unique businesses. A conditional that converted to annual appears in both columns, and the total sums both. Built from the Commission’s own board meeting memoranda, the corrected range is 384 to 439 unique businesses. Against that corrected denominator, the Commission’s July 2026 count of 71 operating cultivators means that fewer than one in five cultivation licenses in New Jersey have produced an operating business, four years in. The rest are stranded somewhere on the path — a town, a building, a lender, a clock.

The market that does exist looks, on one axis, like it is diversifying. Multistate operators held 96.1% of New Jersey flower revenue at the start of 2024; by the close of 2025 their share had fallen to 49.2%, with out-of-state brands at 18.5% and New Jersey-native independents at 32.4%. But the deconcentration happened on top of a collapsing wholesale price, and the structure underneath the numbers has not changed. The state has authorized roughly 2.8 million square feet of cultivation canopy across 73 active licenses. Eleven Tier VI licenses — the largest class — hold 59% of that total. All 19 microbusiness cultivators combined hold 1.7%, less than a third of what a single Tier VI authorizes. Revenue diversified. Canopy did not.

Measured against other markets at the same age, New Jersey sits at the bottom of the band. At fifteen quarters since its first legal sale, New Jersey tracks Illinois — another supply-constrained market — while consuming a fraction of what Michigan and Arizona moved at the identical stage. Whatever is holding New Jersey down, it is not youth, because youth did not hold them down.

None of this is unique to New Jersey. It is the machine every state builds when it legalizes cannabis and then lets its towns opt out — and New Jersey is just far enough along to show the states drafting behind it what the machine produces. Virginia, which legalized retail sales this year with New Jersey’s results already in front of it, enacted a cannabis framework in June 2026 that bans municipal opt-out outright.⁵ The wall that runs through every story in these pages is not a feature of legalizing cannabis. It is a decision New Jersey made — and one it can still revisit. What follows is the case for revisiting it, corroborated by the public record and carried in the words of the people living inside it.

• ¹ NJ-CRC, “High Points,” April 27, 2026 — reports “more than $1.16 billion in sales” for the 2025 calendar year (recreational + medical combined).
• ² NJ-CRC municipal opt-in table, pulled 2026-07-03
• ³ CWG analysis, CRC Atlist dispensary finder (August 2026) vs. U.S. Census 2020
• ⁴ Headset NJ POS data, Q1 2024–Q4 2025, gram-weighted whole-flower
• ⁵ Marijuana Moment, June 29, 2026

What is in the report

• 0 · Who’s Talking, and Why This Report Exists
• 1 · The Convergence
• 2 · Local Control, the Root
• 3 · The Supply Side: Growers Can’t Get In
• 4 · The Demand Side: Local Control Hollows the Market
• 5 · The Entry Gauntlet: What It Costs Just to Get In
• 6 · The Survival Crisis
• 7 · What a Pound Costs
• 8 · Market Concentration and the MSO Advantage
• 9 · After the Lights Come On
• 10 · The Weight of Compliance
• 11 · This Isn’t Just New Jersey
• 12 · What Has to Change
• 13 · For Those Who Come Next
• Appendix A · Interview Index
• Appendix B · Methodology
• Appendix C · Data Sources & Notes
• Appendix D · The Interview Questions and the Outreach

Cite as

Jackson, Max. The New Jersey Cultivator Report: How Municipal Opt-Out Sets the Terms on Both Sides of the Market — in the Words of Twenty-Four Operators. Cannabis Wise Guys, working paper, version 1.0, September 2026. https://doi.org/10.5281/zenodo.22712613

Rights. © 2026 Cannabis Wise Guys. The text and the author’s photographs are released under CC BY-ND 4.0: share the report whole, with credit; do not alter it or excerpt it as a derivative work. Third-party data, the figures derived from it, and all trademarks shown are excluded from that license. Interview material is anonymized under the protocol in Appendix B; quotations should not be reproduced without their surrounding context.

Version. Version 1.0 · September 2026 · DOI 10.5281/zenodo.22712613 · Author ORCID 0009-0001-5777-1792. Corrections and later versions are published at this address.

About this report

I am Max Jackson, founder of Cannabis Wise Guys and Co-Chair of the Cultivation Committee at the New Jersey CannaBusiness Association. I worked at a state-licensed cultivation facility in Trinity County, California, from 2019 to 2022, general manager of the facility in my final year — six flowering greenhouses, 13,000 flowering plants, and a 10,000-plant vegetation facility. On October 6, 2025 I presented Preventing Market Capture in Virginia: An Evidence-Based Risk Assessment to the Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. I write on cannabis policy, published in Marijuana Moment, most recently on the DEA’s rescheduling hearing and on what happened to the hemp industry, and with Chelsea Higgs Wise I co-bylined why Virginia cannabis retail must wait for Virginia cannabis supply in Cardinal News.

This report was self-funded and self-published. No operator, trade association, or government body commissioned or reviewed it prior to publication. No operator interviewed for it was a client of Cannabis Wise Guys at the time of research or publication. If you want to talk about what is in it — as an operator, an investor, or someone writing the rules — email max@cannabiswiseguys.com, pick a time on my calendar, or send it through the form.